🏥 Veterinary UV-C Pathogen Reduction Financial Impact Calculator

Quantify the hidden costs of facility-associated infections and UV-C disinfection value

📋 Facility Information
All clinical and support staff
Surgeries, dental cleanings, invasive procedures
Average fee for procedures with infection risk
Times per week rooms delayed due to pathogen concerns
Lost revenue per room delay event

📚 Evidence-Based Methodology

  • Vet pathogen reduction: ≥97-99.9% (Bordetella, distemper, MS2 - AJVR 2020)
  • Transmission blocking: 100% prevention (hamster respiratory model - Nature 2022)
  • Clinical outcomes: 87% kitten URI reduction (JAVMA 2020); 44.6% surgical infections
  • Base infection rate: 8% for surgical/invasive procedures
  • Staff zoonotic illness: 12.5% annual rate

💰 Current Annual Pathogen Burden

$0
Hidden costs of facility-associated infections

🔍 Current Impact Breakdown

🦠 Estimated Annual Infections
0
💉 Direct Treatment Costs
$0
🏥 Lost Procedure Revenue
$0
🚪 Quarantine/Isolation Costs
$0
⏱️ Room Turnover Delays
$0
👥 Staff Illness & Productivity Loss
$0
📉 Reputation & Client Retention Impact
$0

⚡ Room Turnover Confidence Gap

$0
Annual opportunity cost from delayed room utilization
The Challenge: Concerns about residual pathogens (parvo, CIRD, etc.) delay room turnover even after chemical protocols. UV-C Solution: Portable UV-C devices can inactivate 99.9% of most viruses and bacteria in 5-10 minutes, giving staff confidence to return rooms to service faster. Note: While UV-C directly addresses pathogen concerns, we conservatively estimate 60% improvement in room turnover time to account for operational variability.
✨ Evidence-Based UV-C Pathogen Reduction Value

Conservative Scenario

$0
25% Annual Recoverable Value

Realistic Scenario

$0
42% Annual Recoverable Value

Optimistic Scenario

$0
65% Annual Recoverable Value

📈 3-Year Cumulative Value (Realistic 42%)

$0
Compounding value as reputation improves and client confidence grows

💡 Annual UV-C Value Potential Based on Pathogen Reduction (42%)

🦠 Estimated Reduction in Case Load
0
💰 Potential Treatment Cost Reduction
$0
⏱️ Room Turnover Enhancement
$0
📈 Revenue Protection
$0
👥 Reduced Staff Zoonotic Exposure Costs
$0
Reputation Enhancement Value
$0

🔬 Veterinary-Specific Scientific Evidence

Direct Veterinary Pathogen Studies:

  • Bordetella bronchiseptica (kennel cough): ≥99.9% airborne pathogen reduction in simulated HVAC system (AJVR 2020)
  • Canine distemper virus: ≥97% airborne pathogen reduction (AJVR 2020)
  • Bacteriophage MS2 (parvo surrogate): 99.7% airborne reduction (AJVR 2020)
  • Kitten upper respiratory infections: 87% reduction in clinical cases with continuous UV-C air disinfection (Arizona Humane Society, JAVMA 2020)

Transmission Prevention Studies:

  • Airborne disease transmission blocking: 100% prevention of highly contagious respiratory pathogen transmission via UV-C in HVAC systems (hamster model, Nature Scientific Reports 2022)
  • Control group (no UV-C): 100% infection rate within 24 hours
  • UV-C group: 0% infection rate throughout study period

Human Healthcare Evidence (applicable to veterinary settings):

  • Surgical site infections: 44.6% average reduction
  • Overall facility infection reduction: 42% average (range: 19-70%, meta-analysis of 25 peer-reviewed studies)
  • Multi-drug resistant organisms: 63% reduction

Sources: Jaynes et al. JAVMA 2020; Pearce-Walker et al. AJVR 2020; Shemesh et al. Nature Sci Rep 2022; Maugeri et al. J Hosp Infect 2025

📋 Calculation Methodology

  • Base infection rate: 8% for surgical/invasive procedures (industry standard range: 5-15%)
  • Treatment costs: $800-1,500 per infection (conservative $1,200 default)
  • Room turnover: Weekly delays × 50 weeks × average impact per delay
  • Room turnover UV-C impact: 60% improvement (higher than infection reduction due to confidence-based mechanism)
  • Lost revenue: Procedure cancellations + quarantine periods
  • Staff impact: 12.5% annual zoonotic illness rate × replacement costs
  • Reputation factor: 15% of infection burden (client loss, reduced referrals)
  • 3-year projection: Year 1 × 1.0, Year 2 × 1.15, Year 3 × 1.25 (reputation growth)
  • UV-C pathogen inactivation: >99.9% on adequately exposed air and surfaces (253.7nm germicidal wavelength)
  • UV-C attributed improvements: Conservative 25%, Realistic 42%, Optimistic 65% (based on real-world implementation studies)